Cleared Traditional

K132429 - SPECTRA OPTIA APHERESIS SYSTEM, SPECTRA OPTIA SYSTEM SOFTWARE, SPECTRA OPTIA EXCHANGE DISPOSABLE SET
(FDA 510(k) Clearance)

K132429 · Terumobct, Inc. · Gastroenterology & Urology
Dec 2013
Decision
123d
Days
Risk

K132429 is an FDA 510(k) clearance for the SPECTRA OPTIA APHERESIS SYSTEM, SPECTRA OPTIA SYSTEM SOFTWARE, SPECTRA OPTIA EXCHANGE DISPOSABLE SET. This device is classified as a Separator, Automated, Blood Cell And Plasma, Therapeutic.

Submitted by Terumobct, Inc. (Lakewood, US). The FDA issued a Cleared decision on December 6, 2013, 123 days after receiving the submission on August 5, 2013.

This device falls under the Gastroenterology & Urology FDA review panel.

Submission Details

510(k) Number K132429 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 05, 2013
Decision Date December 06, 2013
Days to Decision 123 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code LKN — Separator, Automated, Blood Cell And Plasma, Therapeutic
Device Class

Similar Devices — LKN Separator, Automated, Blood Cell And Plasma, Therapeutic

All 26
AMICUS Separator System
K192150 · Fresenius Kabi AG · Nov 2019
Spectra Optia Apheresis System
K183081 · Terumobct, Inc. · Feb 2019
AMICUS Separator System, AMICUS Exchange Kit - Therapeutics, Waste Transfer Set, Blood Component Filter Set With Vented Spike and Luer Adapter
K180615 · Fresenius Kabi USA,Llc · Dec 2018
Spectra Optia Apheresis System
K181049 · Terumobct, Inc. · Nov 2018
Spectra Optia Apheresis System
K172590 · Terumobct, Inc. · Mar 2018
Spectra Optia Apheresis System
K153601 · Terumobct, Inc. · Jan 2016